|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine, Cardiology Division, Westchester Medical Center/New York Medical College, Valhalla, NY.
Correspondence to: Wilbert S. Aronow, MD, Cardiology Division, New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595; e-mail: WSAronow{at}aol.com
Study objectives: To determine the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the dipyridamole stress test (DSST) in predicting
50% obstruction of an internal mammary artery or new native coronary artery disease (CAD) compared with saphenous vein graft obstruction
50% in patients with prior coronary artery surgery and symptoms.
Design: In 144 patients with prior coronary artery surgery who underwent a DSST within 8 ± 7 days of coronary angiography performed because of cardiac symptoms, we investigated the sensitivity, specificity, PPV, and NPV of the DSST in predicting
50% obstruction of an internal mammary artery or new native CAD (201 total arterial conduits) vs
50% obstruction of saphenous vein grafts (total saphenous grafts = 246).
Setting: A university hospital.
Patients: The 144 patients included 88 men and 56 women, mean age 68 ± 9 years (± SD).
Results: The DSST had a sensitivity of 81%, a specificity of 87%, a PPV of 84%, and a NPV of 84% in predicting
50% obstruction of an internal mammary artery or new native CAD. The DSST had a sensitivity of 88%, a specificity of 82%, a PPV of 86%, and a NPV of 85% in predicting
50% obstruction of saphenous vein grafts.
Conclusion: There was no significant difference in sensitivity, specificity, PPV, or NPV of the DSST in predicting
50% obstruction of an internal mammary artery or new native CAD vs predicting
50% obstruction of saphenous vein grafts in patients with prior coronary artery surgery and cardiac symptoms.
Key Words: coronary artery disease coronary artery surgery dipyridamole sestamibi stress test internal mammary artery saphenous vein grafts
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |